Morning Read: FDA panel approves Acadia’s Parkinson’s disease treatment
Also, Aveo Pharmaceuticals will pay $4 million to settle charges with the SEC, and EMED Technologies said today that it is seeking a federal court injunction against competitor Repro-Med Systems.